EV Biologics, Inc. (YECO)

EV Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2017	2016	2015	2014	2013
Net Income	-1.27	-21.06	-0.39	-0.1	-0.1	-0.55	-53.19	8.68	10.69
Depreciation & Amortization	0	0	0	0	0.69	2.22	1.75	1.39	1.06
Share-Based Compensation	0	0	0	0	0.16	0.53	0	0	0
Other Operating Activities	-2.02	0.21	1.09	0.2	0.8	11.08	57.64	2.05	-0.39
Operating Cash Flow	-3.28	-20.84	0.7	0.1	1.55	13.28	6.2	12.11	11.36
Operating Cash Flow Growth	-	-	614.45%	-93.70%	-88.33%	114.10%	-48.81%	6.64%	-
Capital Expenditures	-0.04	0	-19.27	0	-1.93	-36.62	-2.03	-0.95	-14.12
Acquisitions	0	6.94	0	0	0	0	0	0	0
Other Investing Activities	10.84	12.85	-2.41	-	-	0.02	0.03	2.6	-2.04
Investing Cash Flow	10.8	19.78	-21.68	0	-1.93	-36.6	-2	1.65	-16.16
Common Stock Issued	0	0	0	0	0	11.51	0	0	0
Other Financing Activities	-7.72	1.99	21.68	-	-0.45	-0.89	-7.59	0.18	6.13
Financing Cash Flow	-7.72	1.99	21.68	0	-0.45	10.62	-7.59	0.18	6.13
Net Cash Flow	-0.21	-0.26	0.5	0.1	-0.92	-13.74	-3.26	13.94	1.47
Free Cash Flow	-3.32	-20.84	-18.57	0.1	-0.38	-23.35	4.18	11.16	-2.76
Free Cash Flow Growth	-	-	-	-	-	-	-62.59%	-	-
Free Cash Flow Margin	-6793.78%	-	-15616.47%	-	-	-246.41%	9.79%	24.15%	-6.20%
Free Cash Flow Per Share	-0.32	-2.88	-2.57	0.01	-0.06	-9.68	1.75	6.98	-1.80

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.